Поисковый запрос: (<.>S=ЛЕЧЕНИЕ МЕТОТРЕКСАТОМ<.>) |
Общее количество найденных документов : 20
Показаны документы с 1 по 20
|
1.
| Seitz Enhanced in vitro induced production of interleukin 10 by peripheral blood mononuclear cells in rheumatoid arthritis is associated with clinical response to methotrexate treatment // J. Rheumatol., 2001. Vol. 28, N 3.-С.496-501
|
2.
| Seitz Enhanced in vitro induced production of interleukin 10 by peripheral blood mononuclear cells in rheumatoid arthritis is associated with clinical response to methotrexate treatment // J. Rheumatol., 2001. Vol. 28, N 3.-С.496-501
|
3.
| In vitro immunomodulatory action of low doses of methotrexate in rheumatic diseases // Scand. J. Immunol., 2001. Vol. 54, прил. 1.-С.116
|
4.
| Methotrexate treatment reduces in a dose-dependent manner the frequency of CLA+CD8+ but not CD4+ T-cells in the blood of psoriatic patients // Scand. J. Immunol., 2001. Vol. 54, прил. 1.-С.97
|
5.
| In vitro immunomodulatory action of low doses of methotrexate in rheumatic diseases // Scand. J. Immunol., 2001. Vol. 54, прил. 1.-С.116
|
6.
| Возможности лечения заболеваний с Th1-типом иммунного ответа на примере ревматоидного артрита // Цитокины и воспаление, 2002. Т. 1, N 2.-С.98-99
|
7.
| Динамика иммунологического фенотипа лейкоцитов под влиянием терапии метотрексатом при ревматоидном артрите // Рос. биотерапевт. ж., 2002. Т. 1, N 4.-С.3-8
|
8.
| Динамика иммунологического фенотипа лейкоцитов под влиянием терапии метотрексатом при ревматоидном артрите // Рос. биотерапевт. ж., 2002. Т. 1, N 4.-С.3-8
|
9.
| Динамика иммунологического фенотипа лейкоцитов под влиянием терапии метотрексатом при ревматоидном артрите // Рос. биотерапевт. ж., 2002. Т. 1, N 4.-С.3-8
|
10.
| Hidalgo Luis A. Management of cervical pregnancy: Risk factors for failed systemic methotrexate // J. Perinat. Med., 2004. Vol. 32, N 2.-С.184-186
|
11.
| The immunosuppressive effect of methotrexate in active rheumatoid arthritis patients vs. its stimulatory effect in nonactive patients, as indicated by cytometric measurements of CD4{+} T cell subpopulations // Immunol. Invest., 2004. Vol. 33, N 3.-С.351-362
|
12.
| The immunosuppressive effect of methotrexate in active rheumatoid arthritis patients vs. its stimulatory effect in nonactive patients, as indicated by cytometric measurements of CD4{+} T cell subpopulations // Immunol. Invest., 2004. Vol. 33, N 3.-С.351-362
|
13.
| The immunosuppressive effect of methotrexate in active rheumatoid arthritis patients vs. its stimulatory effect in nonactive patients, as indicated by cytometric measurements of CD4{+} T cell subpopulations // Immunol. Invest., 2004. Vol. 33, N 3.-С.351-362
|
14.
| Methotrexate therapy of oral corticosteroid-dependent asthmatics reduces serum immunoglobulins: Correlation with clinical response to therapy // Clin. and Exp. Allergy, 2005. Vol. 35, N 5.-С.579-584
|
15.
| Methotrexate therapy of oral corticosteroid-dependent asthmatics reduces serum immunoglobulins: Correlation with clinical response to therapy // Clin. and Exp. Allergy, 2005. Vol. 35, N 5.-С.579-584
|
16.
| Plasma level of CXC-chemokine CXCL12 is increased in rheumatoid arthritis and is independent of disease activity an methotrexate treatment // J. Rheumatol., 2006. Vol. 33, N 9.-С.1754-1759
|
17.
| Plasma level of CXC-chemokine CXCL12 is increased in rheumatoid arthritis and is independent of disease activity an methotrexate treatment // J. Rheumatol., 2006. Vol. 33, N 9.-С.1754-1759
|
18.
| Plasma level of CXC-chemokine CXCL12 is increased in rheumatoid arthritis and is independent of disease activity an methotrexate treatment // J. Rheumatol., 2006. Vol. 33, N 9.-С.1754-1759
|
19.
| Unexplained amenorrhea in a patient taking methotrexate for the treatment of rheumatoid arthritis // Gynecol. Endocrinol., 2010. Vol. 26, N 3.-С.179-180
|
20.
| Unexplained amenorrhea in a patient taking methotrexate for the treatment of rheumatoid arthritis // Gynecol. Endocrinol., 2010. Vol. 26, N 3.-С.179-180
|
&uf('+1W2226#',v2226), ?>
|